Microbial Pathogenesis, Год журнала: 2024, Номер unknown, С. 107172 - 107172
Опубликована: Ноя. 1, 2024
Язык: Английский
Microbial Pathogenesis, Год журнала: 2024, Номер unknown, С. 107172 - 107172
Опубликована: Ноя. 1, 2024
Язык: Английский
Frontiers in Immunology, Год журнала: 2024, Номер 15
Опубликована: Сен. 25, 2024
Idiopathic pulmonary fibrosis (IPF) is the most common and severe form of fibrosis, characterized by scar formation in lung interstitium. Transforming growth factor beta (TGF-β) known as a key mediator fibrotic process, acting on fibroblasts mediating their proliferation differentiation into myofibroblasts. Although immune system not considered responsible for initiation IPF, markers tolerogenic immunity define pro-fibrotic microenvironment lungs. In homeostatic conditions, regulatory T cells (Tregs) constitute main lymphoid population maintaining peripheral tolerance. Similar to Tregs, B (Bregs) represent recently described subset lymphocytes with immunosuppressive functions. context numerous studies have suggested role Tregs enhancing mainly via secretion TGF-β. humans, show increased percentages associated severity although exact remains unclear. mice, commonly used model involves triggering acute inflammation bleomycin, leading subsequent process. Consequently, data are still conflicting, may play protective during inflammatory phase deleterious phase. Bregs been less studied but appears be experimental models fibrosis. This review presents latest updates exploring implication IPF compares different approaches better understand origins conflicting findings.
Язык: Английский
Процитировано
1Journal of Pharmaceutical and Biomedical Analysis, Год журнала: 2024, Номер 252, С. 116515 - 116515
Опубликована: Окт. 10, 2024
Язык: Английский
Процитировано
0Microbial Pathogenesis, Год журнала: 2024, Номер unknown, С. 107172 - 107172
Опубликована: Ноя. 1, 2024
Язык: Английский
Процитировано
0